Literature DB >> 26375995

Adverse Effects of Common Drugs: Adults.

Peter R Lewis1, Kelly Dowhower Karpa2, Todd Matthew Felix1.   

Abstract

Although drugs can be an essential and lifesaving component of the care of adult patients, their use frequently is accompanied by adverse effects and life-threatening adverse drug reactions that can result in significant disability and mortality. The potential for drug-related severe morbidity and mortality is compounded during periods of hospitalization, when high-risk drugs such as anticoagulants or insulin are used, and when care in an intensive care unit is required. Patient factors in adults that can increase the risk of drug harms include immunosuppression, cognitive impairment, depression, alcoholism and other substance abuse disorders, chronic kidney disease, hepatic dysfunction, coagulopathies, limited English proficiency, institutional/nursing home care, and underinsurance or lack of insurance. Physician factors that can increase the risk of drug harms include inappropriate prescribing of drugs (including to pregnant and breastfeeding women), failure to appropriately discontinue/deprescribe drugs, insufficient drug reconciliation, failure to coordinate care among multiple prescribing clinicians, and failure to elicit and incorporate into health histories and clinical decision-making the widespread use of nonprescription drugs, herbal products, and dietary supplements. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26375995

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  2 in total

1.  Data science-driven analyses of drugs inducing hypertension as an adverse effect.

Authors:  Reetu Sharma
Journal:  Mol Divers       Date:  2020-05-15       Impact factor: 2.943

2.  Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study.

Authors:  Antoni Sicras-Mainar; Javier Rejas-Gutierrez; Francisco Vargas-Negrín; Juan Carlos Tornero-Tornero; Aram Sicras-Navarro; Isabel Lizarraga
Journal:  Rheumatol Ther       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.